Abstract:BackgroundOvarian cancer is a very common gynecological malignant tumor. Natural products are important sources of chemotherapy drugs for ovarian cancer. Damnacanthal is an anthraquinone derivative with anti-cancer pharmacological properties.ObjectiveThis study aimed to investigate the mechanisms underlying damnacanthal's effects against ovarian cancer.MethodsIn vitro experiments, CCK8, colony formation and flow cytometry assays were used to evaluate the anti-ovarian cancer effect of damnacanthal on SKVO3 and A2780 cells. The wound healing tests and the transwell invasion assays were used to detect the migration and infiltration of ovarian cancer cells. Western Blot assays and immunofluorescence staining were used to measure autophagy levels. In vivo experiments, the anti-ovarian cancer effect of damnacanthal was further evaluated in a xenograft nude mouse model of SKVO3 cells.ResultsDamnacanthal induced significant cell death and apoptosis, as well as significant inhibition in migration and invasion, in SKVO3 and A2780 cells, Furthermore, damnacanthal induced cell cycle arrest by increasing the protein levels of p27Kip1 and decreasing cyclin D1 levels. In addition, damnacanthal induced a significant accumulation of autophagosomes, accompanied with an increase in LC3II protein levels, and a decrease in p62 protein levels. 3-methyladenine, an autophagy formation inhibitor, significantly mitigated the damnacanthal-induced apoptosis and migration hindrance, as well as the decline in cell viability. Furthermore, the inactivation of ERK and its downstream effector mTOR signaling pathways, rather than Akt or P38 pathway, were involved in damnacanthal's activation in autophagy. In addition, TBHQ, an ERK activator, significantly inhibited damnacanthal-boosted LC3 II levels and autophagosome accumulation, and reversed damnacanthal-induced cell death, apoptosis, cell cycle arrest and migration hindrance. Finally, the anti-ovarian cancer effect of damnacanthal was confirmed in the orthotopic xenograft model of SKVO3 cells in nude mice, with tumor growth being significantly inhibited comparably to the efficacy of cisplatin. Damnacanthal was also synergistic with cisplatin and showed inhibition in cisplatin-resistant ovarian cancer cells.ConclusionDamnacanthal inhibited the growth of ovarian cancer via the ERK/mTOR/autophagy signaling cascade, indicating that it may be a potential anti-ovarian cancer drug candidate.

Activation of P38 MAPK by Damnacanthal Mediates Apoptosis in SKHep 1 Cells Through the DR5/TRAIL and TNFR1/TNF-α and P53 Pathways.

Cantharidin Inhibits Anti-Apoptotic Bcl-2 Family Proteins and Induces Apoptosis in Human Osteosarcoma Cell Lines MG-63 and MNNG/HOS Via Mitochondria-Dependent Pathway.

Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy

Mechanism of Damnacanthal Induced Apoptosis in CEM-SS Cell Line

Myricetin Induces Apoptosis In Hepg2 Cells Through Akt/P70s6k/Bad Signaling And Mitochondrial Apoptotic Pathway

[Action of Apoptosis-Induced Ligand Gene in Relation to Tumor Necrosis Factor on Human Colon Cancer Cell Line HT29].

[Lipopolysaccharide (LPS) Increases Tumor Necrosis Factor-Alpha Related Apoptosis Induced-Ligand (TRAIL) in Macrophages Killing HepG2 Cells].

Mtor Signaling Pathway is Inhibited Downstream of the Cyclophilin D-mediated Mitochondrial Permeability Transition in Honokiol-Triggered Regulated Necrosis.

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Cantharidin Induces Apoptosis of H460 Human Lung Cancer Cells Through Mitochondria-Dependent Pathways.

Cell Death Induced by Ent-11Α-hydroxy-15-oxo-kaur-16-en-19-oic-acid in Anaplastic Thyroid Carcinoma Cells is Via a Mitochondrial-Mediated Pathway

Xanthatin Induces Apoptosis by Activating Endoplasmic Reticulum Stress in Hepatoma Cells

Acute oral toxicity of damnacanthal and its anticancer activity against colorectal tumorigenesis

Involvement of P38 Mitogen-Activated Protein Kinase Pathway in Honokiol-Induced Apoptosis in A Human Hepatoma Cell Line (Hepg2)

Apoptotic Pathway Induced by Diallyl Trisulfide in Pancreatic Cancer Cells

Up-regulation of Death Receptor 4 and 5 by Celastrol Enhances the Anti-Cancer Activity of TRAIL/Apo-2L.

Notch1 Signaling Sensitizes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in Human Hepatocellular Carcinoma Cells by Inhibiting Akt/Hdm2-mediated P53 Degradation and Up-regulating P53-Dependent DR5 Expression*

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

Dihydrotanshinone I induces necroptosis and cell cycle arrest in gastric cancer through the PTPN11/p38 pathway

p38 mitogen-activated protein kinase is required for the antitumor activity of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.

TAK1 is Involved in Sodium L-lactate-stimulated P38 Signaling and Promotes Apoptosis